Health Market Sciences Launches Tool to Find and Recruit Physicians for Clinical Trials
Health Market Science, Inc., a leading source of healthcare provider data and analytics solutions in the United States, announced the launch of Clinical Investigators, their latest innovation for clinical site recruitment.
Health Market Science Launches Clinical Investigators(TM)
The Only All-Inclusive Tool That Clinical Recruiters Need to Achieve Their Trial Site Recruitment Goals
KING OF PRUSSIA, Pa., July 17 /PRNewswire/ -- Health Market Science, Inc., a leading source of healthcare provider data and analytics solutions in the United States, announced today the launch of Clinical Investigators, their latest innovation for clinical site recruitment. Clinical Investigators dramatically reduces the time needed by pharmaceutical companies and contract research organizations (CRO's) to recruit physicians for clinical trials by providing instant online access to one of the industry's most comprehensive, up-to-date national databases of physician reference data, clinical trial experience, and claims volume rankings.
"With more than 80% of clinical trials experiencing delays, the industry is looking for insight into how trial site selection can become a more effective, efficient and repeatable process," says Zach Henderson, Vice President, Marketing and Product Development at Health Market Science. "Clinical Investigators provides our clients a competitive advantage by accelerating the identification and recruitment of the best investigators for their trial protocol.
"Clinical operations executives continue to face the increased pressures of heightened regulatory scrutiny of trial results, soaring R&D costs, and the need to accelerate the time-to-market for new drugs. Clinical Investigators allows users to immediately begin their planning for site recruitment or aid them in the implementation of an effective rescue plan to get their trial back on target as well as reduce additional costs and time delays.
Clinical Investigators links an intuitive web-based user interface with a national, comprehensive database of trial experience detail, claims data, and Health Market Science's Provider Master File. With over 4.5 million individual providers and 1.0 million healthcare organizations, the Health Market Science Provider Master File is a trusted source of physician site detail and affiliations.
About Health Market Science
Health Market Science is the leading source for healthcare provider data and advanced analytics in the United States. Health Market Science has developed unique technology and expertise to continuously acquire, analyze, and integrate over 2,500 distinct data sources to create and maintain the single most comprehensive and accurate source of healthcare provider information available today. The HMS MasterFile(TM) includes detailed reference information for over 4.5 million individual providers and 1.0 million healthcare organizations.
Serving all segments of healthcare, including pharmaceutical manufacturers, biotechs, device manufacturers, payers, providers, and pharmacy chains, Health Market Science is the only company that offers claims information, advanced analytics and the reference data that powers them. This unique combination results in dramatically higher data accuracy and reliability, enabling our customers to increase revenues, drive operational efficiencies, achieve regulatory compliance, and maximize market opportunities.
Recognized on the Inc. 500 as one of the fastest growing private companies in the United States and 10th on Deloitte's Technology Fast 50 Program for Greater Philadelphia, our more than 200 customers include 20 of the top 20 pharmaceutical manufacturers, 10 of the 15 largest device manufacturers, and 3 of the top 5 pharmacy chains. Health Market Science is a privately held company located in King of Prussia, PA. For more information, visit www.healthmarketscience.com. For more information on Clinical Investigators go to http://www.healthmarketscience.com/targeting/clinical-investigators.php
SOURCE Health Market Science, Inc.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
